Determination of famotidine in human plasma and urine by high-performance liquid chromatography

Citation
Tc. Dowling et Rf. Frye, Determination of famotidine in human plasma and urine by high-performance liquid chromatography, J CHROMAT B, 732(1), 1999, pp. 239-243
Citations number
14
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF CHROMATOGRAPHY B
ISSN journal
13872273 → ACNP
Volume
732
Issue
1
Year of publication
1999
Pages
239 - 243
Database
ISI
SICI code
1387-2273(19990910)732:1<239:DOFIHP>2.0.ZU;2-M
Abstract
An improved, rapid and specific high-performance liquid chromatographic ass ay was developed for the determination of famotidine in human plasma and ur ine. Plasma samples were alkalinized and the analyte and internal standard (cimetidine) extracted with water-saturated ethyl acetate, The extracts wer e reconstituted in mobile phase, and injected onto a C-18 reversed-phase co lumn; UV detection was set at 267 nm. Urine samples were diluted with nine volumes of a mobile phase-internal standard mixture prior to injection. The lower limits of quantification in plasma and urine were 75 ng/ml and 1.0 m u g/ml, respectively; intra- and inter-day coefficients of variation were l ess than or equal to 10.5%. This method is currently being used to support renal function studies assessing the use of intravenously administered famo tidine to characterize cationic tubular secretion in man. (C) 1999 Elsevier Science B.V. All rights reserved.